Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins

Author:

Domma Anthony J.1ORCID,Henderson Lauren A.1ORCID,Goodrum Felicia D.23ORCID,Moorman Nathaniel J.4ORCID,Kamil Jeremy P.1ORCID

Affiliation:

1. Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport , Shreveport, Louisiana, USA

2. Department of Immunobiology, University of Arizona , Tucson, Arizona, USA

3. Bio5 Institute, University of Arizona , Tucson, Arizona, USA

4. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina, USA

Abstract

ABSTRACT The phosphoinositide 3-kinase (PI3K)/AKT pathway plays crucial roles in cell viability and protein synthesis and is frequently co-opted by viruses to support their replication. Although many viruses maintain high levels of AKT activity during infection, other viruses, such as vesicular stomatitis virus and human cytomegalovirus (HCMV), cause AKT to accumulate in an inactive state. To efficiently replicate, HCMV requires FoxO transcription factors to localize to the infected cell nucleus (Zhang et al. mBio 2022), a process that is antagonized by AKT. Here, we investigated how HCMV inactivates AKT to achieve this. Results from subcellular fractionation and live-cell imaging studies indicated a defect in the recruitment of AKT to membranes upon serum stimulation of HCMV-infected cells. UV-inactivated virions failed to inactivate AKT, suggesting a requirement for de novo viral gene expression. Through additional studies, we identify that UL38 (pUL38), a viral activator of mTORC1, inactivates AKT by destabilizing insulin receptor substrate-1 (IRS1), a protein that recruits PI3K to growth factor receptors. Decreased electrophoretic mobility and diminished expression of IRS1 correlated with the accumulation of UL38 protein during infection. However, destabilization of IRS1 and loss of AKT activity did not occur in cells infected with an HCMV mutant disrupted for UL38 nor when mTORC1 was inhibited by rapamycin. Finally, ectopic expression of UL38 in uninfected cells sufficed to cause IRS1 degradation and AKT inactivation, and these effects were likewise reversed by rapamycin. Collectively, our results demonstrate that HCMV relies upon a cell-intrinsic negative feedback loop to render AKT inactive during productive infection. IMPORTANCE Human cytomegalovirus (HCMV) requires inactivation of AKT to efficiently replicate, yet how AKT is shut off during HCMV infection has remained unclear. We show that UL38, an HCMV protein that activates mTORC1, is necessary and sufficient to destabilize insulin receptor substrate 1 (IRS1), a model insulin receptor substrate (IRS) protein. Degradation of IRS proteins in settings of excessive mTORC1 activity is an important mechanism for insulin resistance. When IRS proteins are destabilized, PI3K cannot be recruited to growth factor receptor complexes, and hence, AKT membrane recruitment, a rate limiting step in its activation, fails to occur. Despite its penchant for remodeling host cell signaling pathways, our results reveal that HCMV relies upon a cell-intrinsic negative regulatory feedback loop to inactivate AKT. Given that pharmacological inhibition of PI3K/AKT potently induces HCMV reactivation from latency, our findings also imply that the expression of UL38 activity must be tightly regulated within latently infected cells to avoid spontaneous reactivation.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

HHS | NIH | National Institute of General Medical Sciences

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3